Pharmacokinetics of adefovir dipivoxil in monkeys and its distribution in rat tissues

Chinese Journal of Pharmacology and Toxicology

Volumn 17, Issue 6, 2003, Pages 447-450

  Meng, Zhi Yun ^a   Dou, Gui Fang ^a   Sun, Wen Zhong ^a   Zhu, Xiao Xia ^a   Zhang, Liang ^a   Tang, Zhong Ming ^b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Adefovir; Adefovir dipivoxil; Pharmacokinetics

Indexed keywords

ADEFOVIR DIPIVOXIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TISSUE LEVEL; INTESTINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONKEY; NONHUMAN; STOMACH; TISSUE DISTRIBUTION; URINARY EXCRETION;

ALEUTIAN MINK DISEASE PARVOVIRUS (STRAIN G); ANIMALIA;

EID: 0347285465     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Bronson JJ, Ho HT, De Boeck H, Woods K, Ghazzouli L, Martin JC, et al. Biochemical pharmacology of acyclic nucleotide analogues[J]. Ann NY Acad Sci, 1990, 616:398-407.
2. Safrin S. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS[J]. J Acquir Immune Defic Syndr, 1992, 5(Suppl 1):S29-S32.
3. Naesens L, Balzarini J, De Clercq E. Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonyl-methoxyethyl)adenine[J]. Drug Metab Dispos, 1992, 20 (5):745-752.
4. Shaw JP, Louie MS, Krishnamurthy VV, Arimilli MN, Jones RJ, Bidgood AM, et al. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats[J]. Drug Metab Dispos, 1997, 25(3):362-366.
5. Yves B, Bochet M, Thibault V, Calvez V, Fievet MH, Sullivan M. Safety and efficacy of long-term adefovir dipivoxil (ADV) for lamivudine-resistant (LAM-R) HBV in HIV infected patients[J]. J Hepatol, 2002, 36(Suppl 1): S138.
6. Cundy KC, Fishback JA, Shaw JP, Lee ML, Soike KF, Visor GC, et al. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) from three formulations of the prodrug bis (pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys[J]. Pharm Res, 1994, 11(6):839-843.
7. Cundy KC, Barditch-Crovo P, Walker RE, Collier AC, Ebeling D, Toole J, et al. Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients[J]. Antimicrob Agents Chemother, 1995, 39(11): 2401-2405.